| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.49 | $44.31 (0%) | 🛒 Add to cart |
| 180 | $0.39 | $88.63 $70.50 (20%) | 🛒 Add to cart |
| 270 | $0.35 | $132.94 $94.67 (29%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $177.26 $121.86 (31%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.31 | $56.40 $56.40 (0%) | 🛒 Add to cart |
| 360 | $0.27
Best per pill | $112.80 $97.69 (13%) | 🛒 Add to cart |
Similar products
More info:
voltaren
Voltaren, known generically as diclofenac, represents one of the most widely prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) globally. Available in multiple formulations including oral tablets, topical gels, and ophthalmic solutions, it primarily functions as a cyclooxygenase (COX) inhibitor, effectively reducing inflammation, pain, and fever. Its development by Geigy (now Novartis) in the 1970s marked a significant advancement in managing acute and chronic inflammatory conditions, particularly musculoskeletal disorders like osteoarthritis and rheumatoid arthritis.
Rumalaya Gel: Targeted Relief for Musculoskeletal Pain - Evidence-Based Review
Product Description: Rumalaya gel represents one of those interesting formulations that sits right at the intersection of traditional medicine principles and modern topical analgesic development. It’s a polyherbal preparation designed specifically for localized pain and inflammation management, coming as a clear, non-greasy topical gel that absorbs remarkably well without leaving residue. What makes it clinically interesting isn’t just the ingredient list but how these components work synergistically – we’re looking at multiple pathways being modulated simultaneously rather than the single-target approach of most conventional topical NSAIDs.
V-Gel: Advanced Botanical Support for Musculoskeletal Inflammation - Evidence-Based Review
Product Description: V-Gel represents one of those rare convergence points where traditional botanical wisdom meets modern pharmaceutical standards. Developed through a collaboration between our rheumatology department and ethnobotany researchers, this topical gel formulation contains a standardized blend of Boswellia serrata extract (65% boswellic acids), Commiphora wightii (guggulsterones E and Z), and a novel permeation enhancer derived from ginger rhizomes. What makes v-gel particularly interesting isn’t just the ingredient profile - it’s the delivery system that took us three formulation attempts to perfect.
Voveran SR: Sustained Pain Relief for Chronic Inflammatory Conditions - Evidence-Based Review
Voveran SR is a sustained-release formulation of the nonsteroidal anti-inflammatory drug (NSAID) diclofenac sodium, primarily indicated for the management of chronic pain and inflammatory conditions like osteoarthritis and rheumatoid arthritis. Its development aimed to provide prolonged therapeutic effect with less frequent dosing, which we found significantly improved adherence in our long-term pain management clinic. I remember when we first started using it back in the late 90s, the transition from immediate-release diclofenac was a bit contentious among our team—some of the older consultants were skeptical about the pharmacokinetic claims, arguing that the higher peak concentrations of the IR form provided better “breakthrough” coverage for acute flares.
a ret gel
A topical retinoid gel containing 0.025% tretinoin in a stabilized hydrogel base, designed for gradual release and reduced irritation compared to traditional formulations. The formulation includes niacinamide 4% to enhance barrier function and hyaluronic acid 0.5% for sustained hydration throughout the treatment period. Key Components and Bioavailability of Ret Gel The ret gel formulation represents a significant advancement in topical retinoid delivery systems. The primary active ingredient, tretinoin at 0.025% concentration, is stabilized through microencapsulation technology that protects the molecule from oxidative degradation while allowing controlled release.
Abana: Comprehensive Cardiovascular Support Through Multi-Targeted Action - Evidence-Based Review
Product Description Abana represents one of those formulations that initially puzzled me when I first encountered it in integrative cardiology practice. It’s not your standard single-herb supplement but rather a sophisticated polyherbal formulation with roots in Ayurvedic medicine, specifically developed for cardiovascular support. The product typically comes in tablet form and contains a carefully balanced combination of herbs including Terminalia arjuna, Withania somnifera, and Ocimum sanctum among others. What struck me early on was how this formulation approached cardiovascular health from multiple angles simultaneously - something we rarely see in conventional single-agent therapies.
abhigra
Let me tell you about this supplement that’s been creating quite a stir in my practice lately. Abhigra isn’t your typical herbal supplement - it’s a standardized extract from the roots of Withania somnifera, but processed using a proprietary cold-extraction method that preserves the delicate withanolides that give this plant its therapeutic punch. The manufacturer claims this method yields a 15% withanolide concentration, which is substantially higher than most commercial ashwagandha products.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in the atypical antipsychotic class with its unique pharmacodynamic profile. Unlike earlier antipsychotics that primarily functioned as dopamine antagonists, aripiprazole’s mechanism as a partial dopamine agonist created what we initially called a “dopamine stabilizer” - though that term has fallen out of favor in academic circles now. The drug’s development stemmed from Otsuka Pharmaceutical’s research into creating an agent that could modulate dopamine transmission without completely blocking it, addressing both positive and negative symptoms while minimizing extrapyramidal side effects.
Acamprol: Effective Craving Reduction and Neuroregulation in Alcohol Dependence - Evidence-Based Review
In my early neurology practice, we kept hitting a wall with certain patients—those with moderate alcohol dependence who’d failed standard therapies or couldn’t tolerate naltrexone due to hepatic issues. We’d cycle them through counseling, SSRIs, even off-label topiramate, but the relapse rates remained stubbornly high. That’s when our head of research, Dr. Aris Thorne, came back from a European conference buzzing about this compound called acamprol. Honestly, most of us were skeptical.